{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045-0", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045.txt", "chunk_index": 0, "text": "Serogroup B Meningococcal Vaccine (MenB): MedlinePlus Drug Information\nwebsite belongs to an official government organization in the United States.\n(\nLock\nmeans you've safely connected to the .gov website. Share sensitive information only on official, secure websites.\n→\n→\nSerogroup B Meningococcal Vaccine (MenB)\nSerogroup B Meningococcal Vaccine (MenB)\nWhy get vaccinated?\nWhat are meningococcal group B vaccines?\nTalk with your healthcare provider\nWhat are the risks from meningococcal group B vaccines?\nWhat if there is a serious reaction?\nThe National Vaccine Injury Compensation Program\nHow can I learn more?\nBrand names\nWhy get vaccinated?\nMeningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. A different meningococcal vaccine is available that can help protect against serogroups A, C, W, and Y.\nMeningococcal disease can cause meningitis (infection of the lining of the brain and spinal cord) and infections of the blood. Even when it is treated, meningococcal disease kills 10 to 15 infected people out of 100."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045-1", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045.txt", "chunk_index": 1, "text": "ease can cause meningitis (infection of the lining of the brain and spinal cord) and infections of the blood. Even when it is treated, meningococcal disease kills 10 to 15 infected people out of 100. And of those who survive, about 10 to 20 out of every 100 will suffer disabilities such as hearing loss, brain damage, kidney damage, loss of limbs, nervous system problems, or severe scars from skin grafts.\nMeningococcal disease is rare and has declined in the United States since the 1990s. However, it is a severe disease with a significant risk of death or lasting disabilities in people who get it.\nAnyone can get meningococcal disease. Certain people are at increased risk, including:\nInfants younger than one year old\nAdolescents and young adults 16 through 23 years old\nPeople with certain medical conditions that affect the immune system\nMicrobiologists who routinely work with isolates of\nN. meningitidis\n, the bacteria that cause meningococcal disease\nPeople at risk because of an outbreak in their community\nWhat are meningococcal group B vaccines?\nFor best protection, more than 1 dose of a meningococcal B vaccine is needed. There are two meningococcal B vaccines available."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045-2", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045.txt", "chunk_index": 2, "text": "an outbreak in their community\nWhat are meningococcal group B vaccines?\nFor best protection, more than 1 dose of a meningococcal B vaccine is needed. There are two meningococcal B vaccines available. The same vaccine must be used for all doses.\nMeningococcal B vaccines are recommended for people 10 years or older who are at increased risk for serogroup B meningococcal disease, including:\nPeople at risk because of a serogroup B meningococcal disease outbreak\nAnyone whose spleen is damaged or has been removed, including people with sickle cell disease\nAnyone with a rare immune system condition called ''persistent complement component deficiency''\nAnyone taking a type of drug called a \"complement inhibitor,\" such as eculizumab (also called \"Soliris\" ®) or ravulizumab (also called \"Ultomiris\" ®)\nMicrobiologists who routinely work with isolates of\nN. meningitidis\nThese vaccines may also be given to anyone 16 through 23 years old to provide short-term protection against most strains of serogroup B meningococcal disease, based on discussions between the patient and health care provider."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045-3", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045.txt", "chunk_index": 3, "text": "given to anyone 16 through 23 years old to provide short-term protection against most strains of serogroup B meningococcal disease, based on discussions between the patient and health care provider. The preferred age for vaccination is 16 through 18 years.\nTalk with your healthcare provider\nTell your vaccination provider if the person getting the vaccine:\nHas had an allergic reaction after a previous dose of meningococcal B vaccine, or has any severe, life-threatening allergies\nIs pregnant or breastfeeding.\nIn some cases, your health care provider may decide to postpone meningococcal B vaccination until a future visit.\nMeningococcal B vaccination should be postponed for pregnant women unless the person is at increased risk and, after consultation with their health care provider, the benefits of vaccination are considered to outweigh the potential risks.\nPeople with minor illnesses, such as a cold, may be vaccinated."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045-4", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045.txt", "chunk_index": 4, "text": "sk and, after consultation with their health care provider, the benefits of vaccination are considered to outweigh the potential risks.\nPeople with minor illnesses, such as a cold, may be vaccinated. People who are moderately or severely ill should usually wait until they recover before getting meningococcal B vaccine.\nYour health care provider can give you more information.\nWhat are the risks from meningococcal group B vaccines?\nSoreness, redness, or swelling where the shot was given, tiredness, headache, muscle or joint pain, fever, or nausea can happen after meningococcal B vaccination. Some of these reactions occur in more than half of the people who receive the vaccine.\nPeople sometimes faint after a medical procedure, including vaccination. Tell your doctor if you feel dizzy, or have vision changes or ringing in the ears.\nAs with any medicine, there is a very remote chance of a vaccine causing a serious injury or death.\nWhat if there is a serious reaction?\nAn allergic reaction could occur after the vaccinated person leaves the clinic."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045-5", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045.txt", "chunk_index": 5, "text": "ine, there is a very remote chance of a vaccine causing a serious injury or death.\nWhat if there is a serious reaction?\nAn allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.\nFor other signs that concern you, call your health care provider.\nAdverse reactions should be reported to the Vaccine Adverse Event Reporting System (VAERS). Your health care provider will usually file this report, or you can do it yourself. Visit the VAERS website at\nhttps://www.vaers.hhs.gov\nor call\n1-800-822-7967\n.\nVAERS is only for reporting reactions, and VAERS staff does not give medical advice.\nThe National Vaccine Injury Compensation Program\nThe National Vaccine Injury Compensation Program (VICP) is a federal program that was created to compensate people who may have been injured by certain vaccines. Claims regarding alleged injury or death due to vaccination have a time limit for filing, which may be as short as two years."}
{"id": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045-6", "source": "medlineplus_drugs/medlineplus.gov_druginfo_meds_a615045.txt", "chunk_index": 6, "text": "eated to compensate people who may have been injured by certain vaccines. Claims regarding alleged injury or death due to vaccination have a time limit for filing, which may be as short as two years. Visit the VICP website at\nhttps://www.hrsa.gov/vaccinecompensation\nor call\n1-800-338-2382\nto learn about the program and about filing a claim.\nHow can I learn more?\nAsk your health care provider. He or she can give you the vaccine package insert or suggest other sources of information.\nCall your local or state health department.\nVisit the website of the Food and Drug Administration (FDA) for vaccine package inserts and additional information at\nhttps://www.fda.gov/vaccines-blood-biologics/vaccines\n.\nContact the Centers for Disease Control and Prevention (CDC): Call\n1-800-232-4636\n(\n1-800-CDC-INFO\n) or visit CDC's website at\nhttps://www.cdc.gov/vaccines\n.\nBrand names\nBexsero\n®\nTrumenba\n®\nLast Revised -\n03/15/2025"}
